EP 4 - Is the Juice Worth the Squeeze?

Lisa and Colin welcome Nancy Dalin-Peters to Immune Competence. Nancy joins the episode and brings an article that different friends sent to her about the announcement of the new prophylactic monoclonal antibody treatment to help fight COVID-19.

In this discussion, the group discusses the difference between the emergency use approval and full FDA approval for a product, the purpose and different types of monoclonal antibody treatment, and who is approved to start using the product as of right now. An important reminder is that you should always consult your medical teams about treatment options.

We are simply sharing and discussing our own research and breaking down what we, as three members of the PI community, do before contacting our own medical teams. This is not meant to be medical advice.